There was also evidence that CPMs were helpful in avoiding NASH, with the underlying probable processes being linked to the interplay of gut microbiota and BA metabolism, as well as TGR5-mediated NF-κB suppression [67]. Here, GPBAR1 is linked to metabolic dysfunction-associated steatohepatitis.